Introduction
Rotavirus is regarded as the most prevalent causative virus in pediatric gastroenteritis throughout the world. 1 Several studies have revealed that rotavirus is also one of the leading pathogens in Taiwan. [2] [3] [4] Other viruses such as norovirus, adenovirus, and astrovirus also play important roles, but there are only a few related studies in Northern Taiwan. [3] [4] [5] [6] Norovirus, also known as Norwalk-like virus, is classified in a separate genus of Caliciviridae, and three genogroups of norovirus have been identified in humans. The transmission of norovirus is by direct person-to-person contact, or through contaminated food or water. More and more studies have reported that the prevalence of norovirus is higher than expected. [4] [5] [6] [7] [8] Norovirus is associated with several large outbreaks, especially at respiratory care units and nursing homes. [8] [9] [10] The aim of this study was to survey the prevalence and clinical manifestations of the different types of viral gastroenteritis in Taipei between November 2004 and April 2005. We also tried to find out the genogroups of norovirus circulating around Taipei, and the specific clinical presentations associated with norovirus infection.
Methods

Study population
A prospective study was conducted at Mackay Memorial Hospital, which is a tertiary referral hospital in Taipei Stool samples for viral studies were collected from hospitalized pediatric patients with a diagnosis of acute gastroenteritis (ICD-9-CM code: 558.9). The decision to admit to hospital was based on the physician's judgment. Most of the patients had severe diarrhea with dehydration. Patients with critical conditions, underlying bowel diseases, or those on antibiotic before admission, were excluded.
Two kinds of rotavirus vaccine, RotaTeq (Merck & Co., Whitehouse station, NJ, USA) and Rotarix (GlaxoSmithKine Biologicals, Rixensart, Belgium), were not available at Mackay Memorial Hospital during the study period, but some rotavirus vaccine trials were proceeding. Those patients who had received a trial rotavirus vaccine were also excluded from the study, as were specimens of inadequate quantity, and those with mixed infections.
Laboratory analysis
After admission, cultures for stool bacteria and enteric viruses were performed. For the bacteria cultures we used rectal swabs for stool sampling, and each stool sample was cultured using the streak plate method on culture media with Hektoen enteric, Salmonella-Shigella and Campylobacter agars. If no pathogen was isolated after 72 hours, the result was deemed negative. For the viral tests, specimens were collected and stored at −20ºC before analysis. Stool rotavirus was tested for using specific commercial enzyme immunoassay kits (Premier™ Rotaclone kit; Meridian Diagnostics, Cincinnati, OH, USA). 11 All samples were tested in duplicate for norovirus, enteric adenovirus, and astrovirus using the IDEIA™ NLV EIA kit (Norwalk-like virus), code no. K6043 (DakoCytomation Ltd., Ely, United Kingdom). 12 Each sample was added to microwells, and incubated simultaneously with a norovirus specific genogroup I, or genogroup II, polyclonal antibody according to the manufacturer's instructions. The presence of specifically bound enzymelabeled antibody in the wells resulted in a color change.
Clinical comparison
Clinical manifestations, laboratory data, and hospitalization courses were analyzed. Mucoid, or blood-tinged stools were recorded as positive in character. Complete blood counts, C-reactive protein (CRP) levels, and electrolytes were compared between the different pathogens. In addition, the age of admission was divided into four groups: < 6 months old; 6-24 months old; 25-60 months old; and > 60 months old. The prevalence of the different pathogens within each age group was then compared. The clinical presentations of the most common pathogens, i.e. norovirus and rotavirus, were then subjected to detailed comparison.
Statistical analysis
To compare the clinical manifestations and laboratory tests for the different pathogens, we used SPSS version 13.0 (SPSS Inc., Chicago, IL, USA). A χ 2 test was used for categorical data, and an independent-samples t test was used for continuous parameters. A p value < 0.05 was considered statistically significant.
Results
Two hundred pediatric patients were admitted with a diagnosis of gastroenteritis during the 6-month study period. A total of 75 stool specimens were collected according to our design, and the sampling fraction was 37.5%. Most of the patients infected were under 2 years of age (22/39; 56.4%). There was no significant difference in the age distribution between patients with norovirus and rotavirus gastroenteritis (independent t test; p = 0.573) ( Table 2) .
Generally, the patients with norovirus gastroenteritis had milder symptoms than those with other infections. When compared with rotavirus infections, the norovirus infected patients had a lower percentage of fever (6/15 vs. 9/9; p = 0.003), vomiting (3/15 vs. 6/9; p = 0.022), and shorter hospital stays (3.33 vs. 6.67 days; p = 0.006). Lower leukocyte counts and CRP levels were also noted, but the differences were not statistically significant. There were no deaths or serious complications in this series.
Discussion
Rotavirus remains the most prevalent viral pathogen in Taiwan according to several studies. 2,3,5,13 Surprisingly, the prevalence of norovirus is greater than that of rotavirus in our study. Table 3 compares the prevalence of norovirus reported by various investigators in Taiwan, Thailand and Japan. Our findings are similar to levels reported in other studies such as those by Veeravigrom et al in Thailand (22.7%), 14 and Colomba et al in Italy (18.6%). 15 Chen et al reported the prevalence of norovirus to be as high as 29.3%, but half of the patients had mixed infections, 3 so the prevalence of an isolated norovirus infection was only 14.6%. We excluded mixed infections from our study. A survey in 1975 showed that 24% of Taiwanese children between 6-12 years old were positive for anti-Norwalk antibody. 16 The prevalence of norovirus has been shown to change over time, and in different areas. There are several genogroups of norovirus. Genogroups I and II are the most common in human gastroenteritis, although this may vary in different areas, years, seasons, and outbreaks. 17, 18 In this study, genogroup II was the predominant type, as was reported in another study done in Northern Taiwan during a similar period to our study; that series had a similar norovirus prevanence of 21.9%. 4 However, another study performed one year earlier in Northern Taiwan showed the prevalence of norovirus to be low (11.7%), and genogroup I was the dominant type. 17 The predominant genogroup in Osaka, Japan, during five winters (1996-2000) was genogroup II. 18 The commercial enzyme-linked immunoassay (EIA) kit used for norovirus detection in this study, IDEIA NLV, contains several strains: genogroup I (Desert Shield, Norwalk, Southampton, Chiba), and genogroup II (Camberwell, three different Toronto/Mexico strains, Snowy Mountain, two different Hawaiian strains, and three Japanese isolates). The sensitivity and specificity of our kit was 55.5% and 98.3%, respectively. 21 The diagnostic EIA method has promising specificity, but unsatisfactory sensitivity, which may result in a lower detection rate. Some new strains have been noted in other outbreaks of norovirus gastroenteritis but they are, as yet, undetectable by these commercial EIA kits. Electron microscopy and reverse transcription-polymerase chain reaction are regarded as the diagnostic gold standards, but their clinical applications are relatively limited. The EIA method is more suitable for preliminary screening.
22
Generally speaking, the severity of clinical manifestations of norovirus infection is relatively milder than other infections, 4, 23 as also shown in our data. The most common symptoms are fever, vomiting and diarrhea. Severe norovirus infections may occur in infants, elders, or immunocompromised patients. Benign seizures have also been noted in patients with norovirus infections. 24 No seizures, or other complications, developed in our study population. Norovirus may be the major non-bacterial pathogen in outbreaks of gastroenteritis, 19, 25 and both children and adults are susceptible, 9 and re-infection may occur. 26 Because the severity of the clinical symptoms is milder than for other bacterial-and rotavirus-mediated types of enteritis, subclinical infection is easily neglected. There fore, outbreaks follow. Over the period of our study, there was no cluster of infection noted in our study population. The spread of norovirus is rapid, and the main transmission pathway is via contaminated food and person-to-person contact. 19 Early detection reminds us of the importance of decontamination measures, rather than the unnecessary use of antibiotics. In our study, we saw no evidence of a cluster of infections. Both rotavirus and norovirus are common in cold seasons, and norovirus usually hits its peak earlier. 2, 3, 27 Our study covered the period between late fall, winter, and early spring, and rotavirus is considered to be the most prevalent virus in these seasons. Therefore, the higher prevalence of norovirus relative to rotavirus indicates a real disease burden of norovirus.
There are several limitations of our study. Our study was conducted in only one institution, and only sampled over a 6-month period. Since norovirus infection tends to be mild, and the serious gastroenteritis patients tends to be handled by the specialists within gastroenterology or infectious diseases, the high prevalence of norovirus infection may have been underestimated. Rotavirus vaccines were not available in Taiwan during the study period. Since rotavirus vaccines are used in Taiwan now, the prevalence of norovirus gastroenteritis may increase in the future. 28 In conclusion, norovirus was determined to be the most common viral pathogen in Taipei between winter 2004 and spring 2005, in children hospitalized with gastroenteritis. The emergence of norovirus infections in Taipei demands the awareness and attention of clinicians worldwide.
